Myeloma Pacients Europe Breaking News (February 2013)
Pomalidomide (Pomalyst®) approved by Food and Drug Administration (FDA) for use in the United States
„Societal Impact of Pain” (SIP) – 3rd European Symposium Press Release (March 2012)
International Multi-Stakeholder Platform to discuss the Position of Chronic Pain amongst Chronic Diseases
Myeloma Euronet Press Release (April 2008)
Myeloma Euronet welcomes European approval of Thalidomide Pharmion
Myeloma Euronet (February 2008)
Comments on the European Commission Public Consultation „Rare Diseases: Europe’s Challenges”
Myeloma Euronet Press Release (February 2007)
Results of the International Survey rolled out during May – Oct 2006
Late Diagnosis and Slow Drug Approval are the Greatest Barriers to Multiple Myeloma Treatment and Care
Myeloma Euronet Summary Report (February 2007)
International Survey (May – Oct 2006): Barriers to Myeloma Diagnosis, Treatment and Care
National Institute for Health and Clinical Excellence (UK) (October 2006)
Final Ruling on Velcade made Public Early – Joint Statement from Charities in Response to the Decision
Myeloma Euronet Press Release (September 2006)
Patients, Physicians and Scientists call for Greater Action in the Fight against Multiple Myeloma
Myeloma Euronet Announcement (June 2006)
Treatment Update and International Panel Discussion on Access to Treatment and Care for Myeloma Patients in Europe
Myeloma Euronet Meeting Agenda (June 2006)
Treatment Update and International Panel Discussion on Access to Treatment and Care for Myeloma Patients in Europe
Myeloma Euronet Press Release (June 2006)
Myeloma Euronet empowers Pacients and highlights Inequalities in Access to Treatment and Care for Myeloma Patients in Europe
Myeloma Euronet Survey (May 2006)
Myeloma Euronet launches International Survey on Barriers to Myeloma Diagnosis, Treatment, and Care
Survey Results (February 2007)
European Cancer Patient Coalition Press Release (January 2006)
“Warsaw Declaration” will save Lives say Leading Cancer Patient Groups
European Organization for Rare Diseases (November 2005)
“Rare Diseases: understanding this Public Health Priority”
Myeloma Euronet Press Release (June 2005)
First Ever European Network of Myeloma Patient Groups Launched at the 10th Congress of the European Hematology Association (EHA) in Stockholm
European Organization for Rare Diseases Press Release (June 2004)
Thalidomide: Patients denounce the Withdrawal of the Marketing Authorization Application for Multiple Myeloma Treatment.